Crystal deal toy commemorating a follow-on offering by Gritstone Oncology, a clinical-stage biotechnology firm focused on cancer immunotherapies. Goldman Sachs and Cowen and Company acted as joint book-running managers for the offering.
(9ALJ202)
Crystal deal toy commemorating a follow-on offering by Gritstone Oncology, a clinical-stage biotechnology firm focused on cancer immunotherapies. Goldman Sachs and Cowen and Company acted as joint book-running managers for the offering.
(9ALJ202)
Side view of custom crystal tombstone recognizing a follow-on offering of common stock by Gritstone, a California-based biotech firm. (9ALJ202)